NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/11/2026
Back to search
Official data from USPTO
IMATRIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
06/12/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5
Filing date
05/14/2020
Registration date
05/31/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/31/2022
Last transaction
06/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
SMITH, CYNTHIA RINALDI
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nippi, Incorporated
Representatives
R. Scott Keller Warner Norcross + Judd LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Proteins for use in the manufacture of pharmaceuticals and biological preparations other than for medical or veterinary use; Proteins in raw material form for scientific and medical research use to enhance cell proliferation and viability, other than for medical or veterinary use; proteins in raw material form for scientific and medical research use as substrates in cell cultures, other than for medical or veterinary use; biological reagents for scientific and medical research use in cell cultures other than for medical or veterinary use; chemical preparations for scientific and medical research use in cell cultures other than for medical or veterinary use; chemical reagents for use in cell cultures other than for medical or veterinary use; proteins in raw material form for scientific and medical research, other than for medical or veterinary use; chemical preparations for scientific and medical research use other than for medical or veterinary use; chemical reagents other than for medical or veterinary use
Class 5
Cell culture substrates, namely, protein specifically adapted for use with nucleic acid sequences for use in cell cultures for medical, clinical, and veterinary diagnostic use; reagents for use in cell cultures for medical, clinical medical, and veterinary diagnostic use; proteins specially adapted for use with nucleic acid sequences for medical purposes; chemical reagents for medical and veterinary use; chemical preparations for medical purposes, namely, reagents for medical use
Publications
History of USPTO decisions and trademark events.
42 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/15/2022
FIMP
FINAL DISPOSITION PROCESSED
09/15/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/31/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/31/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
04/24/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/16/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/16/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/11/2022
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/14/2021
PUBO
PUBLISHED FOR OPPOSITION
12/14/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/24/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/24/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/17/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/19/2021
GNFR
FINAL REFUSAL E-MAILED
04/19/2021
CNFR
FINAL REFUSAL WRITTEN
04/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/29/2021
RFNT
REFUSAL PROCESSED BY IB
11/02/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/10/2020
RFRR
REFUSAL PROCESSED BY MPU
10/10/2020
MAFR
APPLICATION FILING RECEIPT MAILED
09/22/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/19/2020
CNRT
NON-FINAL ACTION WRITTEN
09/18/2020
DOCK
ASSIGNED TO EXAMINER
09/16/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/15/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/10/2020
Continuous trademark protection
Get notified about every new filing that threatens IMATRIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.